Literature DB >> 15138186

Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats.

M Schultz1, K Munro, G W Tannock, I Melchner, C Göttl, H Schwietz, J Schölmerich, H C Rath.   

Abstract

An overly aggressive immune response to the intestinal microflora in a genetically susceptible host background has been implicated in the pathogenesis of inflammatory bowel diseases. We measured the impact of a probiotic preparation (SIM) containing inulin on the severity of colitis and on intestinal microflora profiles of HLA-B27-beta(2)-microglobulin transgenic (TG) rats. SIM is a mixture of lactobacilli, bifidobacteria, and inulin. Two-month-old TG rats received either SIM or water. Control TG rats received metronidazole, alone or in combination with SIM, for 8 weeks. Nontransgenic rats received SIM or water. The cecal content was removed for analysis of the intestinal microflora by PCR combined with denaturing gradient gel electrophoresis. The colon was scored for histological evidence of inflammation, colonic myeloperoxidase activity and interleukin-1beta RNA levels were measured photometrically or by real-time quantitative PCR. At 4 months, the colonic inflammation of TG rats treated with SIM was histologically diminished compared to that in untreated TG rats (2.2 +/- 0.2 versus 2.9 +/- 0.1; P </= 0.03). The administration of SIM altered the microflora profiles of TG rats by increasing the diversity and stimulating specifically the growth of Bifidobacterium animalis. The probiotic bacteria added to SIM were below the detection level in cecal stool samples at the end of the study period. The administration of SIM resulted in a measurable impact on the cecal microflora profiles of TG rats with attenuation of colitis. The lack of detection of any added probiotic bacteria in the cecal content suggests that prebiotic inulin is the major effective compound.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138186      PMCID: PMC404565          DOI: 10.1128/CDLI.11.3.581-587.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  38 in total

Review 1.  A molecular view of the intestinal ecosystem.

Authors:  E E Vaughan; F Schut; H G Heilig; E G Zoetendal; W M de Vos; A D Akkermans
Journal:  Curr Issues Intest Microbiol       Date:  2000-03

2.  Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis.

Authors:  Carlo F M Welters; Erik Heineman; Frederik B J M Thunnissen; Anthony E J M van den Bogaard; Peter B Soeters; Cor G M I Baeten
Journal:  Dis Colon Rectum       Date:  2002-05       Impact factor: 4.585

Review 3.  Probiotics in the management and prevention of atopy.

Authors:  John Bienenstock; Ryan E Wiley; G Scott Neigh; Susan Waserman; Paul Keith
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

Review 4.  Probiotics for infectious diarrhoea.

Authors:  E Isolauri
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

Review 5.  Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.

Authors:  F Cremonini; S Di Caro; E C Nista; F Bartolozzi; G Capelli; G Gasbarrini; A Gasbarrini
Journal:  Aliment Pharmacol Ther       Date:  2002-08       Impact factor: 8.171

6.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

7.  Effects of dietary fat source and subtherapeutic levels of antibiotic on the bacterial community in the ileum of broiler chickens at various ages.

Authors:  Ane Knarreborg; Mary Alice Simon; Ricarda M Engberg; Bent Borg Jensen; Gerald W Tannock
Journal:  Appl Environ Microbiol       Date:  2002-12       Impact factor: 4.792

8.  Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment.

Authors:  L A Dieleman; M S Goerres; A Arends; D Sprengers; C Torrice; F Hoentjen; W B Grenther; R B Sartor
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

9.  CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice.

Authors:  Florian Obermeier; Nadja Dunger; Ludwig Deml; Hans Herfarth; Jürgen Schölmerich; Werner Falk
Journal:  Eur J Immunol       Date:  2002-07       Impact factor: 5.532

10.  Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.

Authors:  P Seksik; L Rigottier-Gois; G Gramet; M Sutren; P Pochart; P Marteau; R Jian; J Doré
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

View more
  16 in total

1.  Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?

Authors:  P Marteau
Journal:  Gut       Date:  2006-12       Impact factor: 23.059

Review 2.  Probiotics and prebiotics in chronic inflammatory bowel diseases.

Authors:  Julia B Ewaschuk; Levinus A Dieleman
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 3.  Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis.

Authors:  Laura J Dixon; Amrita Kabi; Kourtney P Nickerson; Christine McDonald
Journal:  Inflamm Bowel Dis       Date:  2015-04       Impact factor: 5.325

Review 4.  Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?

Authors:  Roberto Bringiotti; Enzo Ierardi; Rosa Lovero; Giuseppe Losurdo; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 5.  Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.

Authors:  Larissa S Celiberto; Franziska A Graef; Genelle R Healey; Else S Bosman; Kevan Jacobson; Laura M Sly; Bruce A Vallance
Journal:  Immunology       Date:  2018-05-16       Impact factor: 7.397

Review 6.  Gut inflammation and microbiome in spondyloarthritis.

Authors:  Jayakanthan Kabeerdoss; Pulukool Sandhya; Debashish Danda
Journal:  Rheumatol Int       Date:  2015-12-30       Impact factor: 2.631

Review 7.  Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity.

Authors:  Jessica Soldavini; Jonathan D Kaunitz
Journal:  Dig Dis Sci       Date:  2013-07-10       Impact factor: 3.199

Review 8.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

Review 9.  The interplay between fiber and the intestinal microbiome in the inflammatory response.

Authors:  Shiu-Ming Kuo
Journal:  Adv Nutr       Date:  2013-01-01       Impact factor: 8.701

Review 10.  Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis.

Authors:  Matthew J Bull; Nigel T Plummer
Journal:  Integr Med (Encinitas)       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.